/ Jubilant Receives ANDA Approval Bupropion Hydrochloride Tablets ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Thursday, 6 July 2017

Jubilant Life Sciences Ltd. Is the integrated global Pharmaceutical and Life Sciences Company it announced that the Jubilant Pharmaceutical Limited is an owned subsidiary company and one of its received Abbreviated New Drug Application for the final approval of the Bupropion Hydrochloride Tablets 150 mg, and 300 mg for the generic version of welburtrin XL and it is for the treatment for the depressivedisorder and for the prevention of the seasonal affective disorder.

From the USFDA it received the fourth approval during this financial year. On March 31,2017, Jubilant Life sciences it has a total of 81 ANDA's for Oral Solids fields in the US and 51 of them have been approved.

The company is also engaged in the manufacturing and supplying of solid Dosage formulations, Allergy therapy Products, API's and Contract Manufacturing of Sterile and Non Sterile and get approved manufacturing facilities in USA, India and Canada.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717